Clinical Trials on Contact Lens Dry Eye in Belgium

Total 20 results

Beaver-Visitec International, Inc.

Completed

Clinical Study to Investigate Visual Performance of a Hydrophobic Monofocal IOL After Bilateral Implantation (PHY1801)

Cataract | Lens Opacities

Belgium
Beaver-Visitec International, Inc.

Completed

A-constant Optimization of a Toric Monofocal IOL

Cataract

Belgium
University of Liege

Completed

Comparison of Two Sedation Versus Placebo Techniques During Cataract Surgery Under Local Anesthesia

Cataract | Sedation

Belgium
Universitaire Ziekenhuizen KU Leuven

Terminated

CT Lucia 601 IOL Implantation in the Sulcus (CLUS)

Posterior Capsule Tear | Cataract; Complicata | Lens Dislocation

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Outcome of Zeiss AT LARA EDOF Lens Implantation in Vitrectomized Eyes (LARA)

Cataract | Vitreous Disorder

Belgium
Ziemer Ophthalmic Systems AG

Recruiting

FLACS in Pediatric Patients Using FEMTO LDV-Z8

Cataract in Child

Belgium
Allergan

Completed

A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

Dry Eye Disease

France, Spain, Russian Federation, Belgium, Germany, Italy, United Kingdom, Australia
Universitaire Ziekenhuizen KU Leuven
Laboratoires Thea

Recruiting

Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery (GIST)

Age-related Cataract

Belgium
Ophtec BV

Completed

Clinical Trial With PRECIZON Presbyopic

Cataract | Presbyopia

Belgium, Germany, Netherlands, Spain, Turkey
City, University of London
Santen Gmbh; The European Society of Cataract and Refractive Surgeons(ESCRS)

Completed

Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery

Endophthalmitis

United Kingdom, Italy, Turkey, Austria, Belgium, Germany, Poland, Portugal, Spain
argenx
Iqvia Pty Ltd

Active, not recruiting

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (Rho plus)

Primary Sjögren's Syndrome

Belgium, Hungary, Poland
argenx
Iqvia Pty Ltd

Completed

A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) (rho)

Primary Sjögren's Syndrome

Belgium, Poland, Hungary, Netherlands
Maastricht University Medical Center
European Society of Cataract and Refractive Surgeons

Completed

PRevention of Macular EDema After Cataract Surgery (PREMED)

Diabetes Mellitus | Cataract | Cystoid Macular Edema

Netherlands, Austria, Belgium, Germany, Hungary, Portugal, Spain
Novartis Pharmaceuticals

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome (LOUiSSe)

Sjögren Syndrome

Spain, United States, Belgium, Hungary, Germany, Switzerland, Australia, Denmark, China, Taiwan, United Kingdom, Bulgaria
Sanofi

Completed

Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) (phaethuSA)

Sjogren's Syndrome | Sjögren's Syndrome

Belgium, Taiwan, Korea, Republic of, United States, Argentina, Canada, Chile, France, Germany, Hungary, Mexico, Spain
Novartis Pharmaceuticals

Completed

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)

Primary Sjogren Syndrome

United States, Belgium, Italy, Austria, Israel, France, Germany, Hungary, Netherlands, United Kingdom, Japan, Portugal, Argentina, Spain, Taiwan, Russian Federation, Romania, Chile, Poland
Novartis Pharmaceuticals

Recruiting

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-1)

Sjogren Syndrome

Brazil, Portugal, United States, Belgium, Spain, Chile, Germany, Korea, Republic of, Guatemala, Czechia, Mexico, France, Turkey, China, Austria, Poland, Singapore, Lithuania
Novartis Pharmaceuticals

Recruiting

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. (NEPTUNUS-Ext)

Sjogrens Syndrome

Japan, United States, Spain, Austria, Belgium, Germany, Turkey, Hungary, Israel, Taiwan, Italy, France, Colombia, Argentina, Portugal, Australia, Slovakia, United Kingdom, Guatemala, Brazil, Czechia, Poland, Bulgaria, Canada, Lithuania, R...
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)

Sjögren's Syndrome

United States, Australia, Germany, Korea, Republic of, Austria, China, Spain, Japan, Puerto Rico, Poland, Canada, Hungary, Chile, Denmark, France, Italy, Mexico, Peru, Netherlands, Belgium, Brazil, Colombia, United Kingdom, Portugal, Sw... and more
Bristol-Myers Squibb

Completed

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Autoimmune Disorder | Primary Sjögren's Syndrome

United States, Argentina, Belgium, France, Germany, Mexico, Poland, Spain, Netherlands, United Kingdom

Clinical Trials on Contact Lens Dry Eye in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations